Neurocrine Biosciences

This Mental Health Awareness Month, we’re proud to join the conversation with NAMI to encourage others to raise awareness, share your story, and break the stigma around mental health. Every experience that is shared strengthens the community and reminds us that healing happens together. #MHAM 

We are honored to recognize Senior Specialist of Business Development Serena Lee, during Asian American and Pacific Islander Heritage Month. Serena serves as Chair of the Asian Employee Resource Network, which is hosting a celebratory company-wide event this month featuring our Chief Medical Officer Sanjay Keswani. 

Today we announced new real-world data highlighting the functional impact of clinician-reported mild tardive dyskinesia movements on patients. Survey findings show that perceived mild involuntary movements can affect patients’ overall functional status, independence, activities of daily living and ability to work. Results were presented at the American Psychiatric Association 2026 Annual Meeting. https://lnkd.in/gMCCPAMx

Today we announced the completion of our acquisition of Soleno Therapeutics, Inc. We welcome our Soleno colleagues to Neurocrine and share their deep commitment to the Prader-Willi syndrome community. https://lnkd.in/giVrGpsG

During #TDAwarenessWeek, advocacy and community leaders visited Neurocrine’s headquarters, where they spoke about innovation in mental health treatments, access to care, and opportunities for strengthening support for patients living with mental health condition. We are thankful for all who attended and made this event possible!

Headed to #PsychCongressElevate2026? Join us for our annual DIMD Conference program! We’ll be at the Psych Congress Elevate Private Practice Summit Preconference on June 2 at Caesars Palace in Las Vegas. These two interactive sessions are designed to educate healthcare professionals about tardive dyskinesia and drug-induced movement disorders (DIMDs). To attend the DIMD Conference program, you must be registered for Psych Congress Elevate and the Private Practice Summit Preconference. Register now for Psych Congress Elevate and check the box to add the Private Practice Summit Preconference: https://lnkd.in/dzS4_wta

Tardive dyskinesia advocates came together to share their personal stories and highlight the needs of the TD community during TD Hill Day in Washington, D.C. We were proud to support this effort with the Center for Patient Advocacy Leaders (CPALs) and Grammy®-nominated singer-songwriter, mental health advocate and paid spokesperson for Neurocrine, Carnie Wilson.

Meet Senior Architect of Cyber Security Daniel Navetta. Daniel’s journey started on the help desk team, where curiosity and problem-solving laid the groundwork for his growth in cyber security. He’s guided by one of our core values – integrity, which brings purpose to his everyday work. https://lnkd.in/gctse4SD

Neurocrine Biosciences is proud to receive Mental Health America’s 2026 Gold Bell Seal for Workplace Mental Health. This recognition places us among a select group of organizations that are committed to supporting employees’ mental health and well-being. We are honored to continue fostering a healthy and supportive workplace. https://lnkd.in/gzW_q3U4 #MentalHealth #WorkplaceMentalHealth

The involuntary movements people living with tardive dyskinesia (TD) experience can impact their physical, social and emotional wellbeing. This #TDAwarenessWeek, visit TalkAboutTD.com to hear real stories from people living with TD.   #NeurocrineBiosciences